IMMUNOHISTOCHEMICAL TECHNIQUES IN MOHS MICROGRAPHIC SURGERY - THEIR POTENTIAL USE IN THE DETECTION OF NEOPLASTIC-CELLS MASKED BY INFLAMMATION

被引:31
作者
JIMENEZ, FJ
GRICHNIK, JM
BUCHANAN, MD
CLARK, RE
机构
[1] Dermatologic Surgery and Cutaneous Oncology Unit, Division of Dermatology, Department of Medicine, NC
关键词
D O I
10.1016/0190-9622(95)90190-6
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Histopathologic evaluation of tissue obtained from Mohs micrographic surgery is the key step in obtaining complete tumor removal. Residual undetected tumor may result in recurrence. Objective: In circumstances in which the histopathologic interpretation is difficult, we assessed the potential use of immunohistochemical techniques to detect tumor in Mohs micrographic surgical specimens. Methods: A rapid immunoperoxidase technique with monoclonal anticytokeratin antibodies was performed on Mohs frozen sections. Cases selected included morpheaform basal cell carcinomas, perineural tumors, and sections with dense inflammation without apparent tumor. Results: Four cases are described as examples that highlight the potential usefulness of immunostaining of Mohs tissue sections. Anticytokeratin antibodies helped to confirm free tumor margins, thus avoiding the unnecessary sacrifice of normal tissue, and to delineate tumor not identified in hematoxylin and eosin frozen sections. Conclusion: Immunohistochemical staining of Mohs micrographic surgical specimens with anticytokeratin antibodies is particularly useful when dense inflammatory infiltrate is present, because the latter may obscure any residual tumor. Application of this technique to difficult cases may prevent tumor recurrences or unnecessary excision of normal tissue.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 19 条
  • [1] DERMATOFIBROSARCOMA PROTUBERANS IS A UNIQUE FIBROHISTIOCYTIC TUMOR EXPRESSING-CD34
    AIBA, S
    TABATA, N
    ISHII, H
    OOTANI, H
    TAGAMI, H
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1992, 127 (02) : 79 - 84
  • [2] INFLAMMATORY ONCOTAXIS
    DERHAGOPIAN, RP
    SUGARBAKER, EV
    KETCHAM, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 240 (04): : 374 - 375
  • [3] LENTIGO-MALIGNA - THE USE OF RUSH PERMANENT SECTIONS IN THERAPY
    DHAWAN, SS
    WOLF, DJ
    RABINOVITZ, HS
    POULOS, E
    [J]. ARCHIVES OF DERMATOLOGY, 1990, 126 (07) : 928 - 930
  • [4] CHEMOSURGICAL REPORT - RECURRENCE (PERSISTENCE) OF TUMOR FOLLOWING EXCISION BY MOHS SURGERY
    DZUBOW, LM
    [J]. JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1987, 13 (01): : 27 - 30
  • [5] FALSE-NEGATIVE TUMOR-FREE MARGINS FOLLOWING MOHS SURGERY
    DZUBOW, LM
    [J]. JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1988, 14 (06): : 600 - 602
  • [6] IMMUNOHISTOCHEMICAL MARGIN CONTROL APPLIED TO MOHS MICROGRAPHIC SURGICAL EXCISION OF DERMATOFIBROSARCOMA PROTUBERANS
    JIMENEZ, FJ
    GRICHNIK, JM
    BUCHANAN, MD
    CLARK, RE
    [J]. JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1994, 20 (10): : 687 - 689
  • [7] Kaplan R P, 1986, Adv Dermatol, V1, P3
  • [8] KERATIN EXPRESSION IN BASAL-CELL CARCINOMAS
    MARKEY, AC
    LANE, EB
    MACDONALD, DM
    LEIGH, IM
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1992, 126 (02) : 154 - 160
  • [9] MCNUTT MA, 1988, MONOCLONAL ANTIBODIE, P51
  • [10] Mikhail GR, 1991, MOHS MICROGRAPHIC SU